RSS Parrot

Antidepressant withdrawal symptoms more common among long-term users, study finds

https://medicalxpress.com/news/2025-05-antidepressant-symptoms-common-term-users.html

Published: May 22, 2025 04:29

People who have been taking antidepressants for more than two years are substantially more likely to experience withdrawal symptoms compared to short-term users when they come off the medication, finds a new study led by UCL researchers.

FDA approves Zynyz as first-line treatment for advanced anal cancer

https://medicalxpress.com/news/2025-05-fda-zynyz-line-treatment-advanced.html

Published: May 21, 2025 17:07

The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first first-line treatment for advanced anal cancer.

Generic drugs can be reliably supplied at big savings, study finds

https://medicalxpress.com/news/2025-05-generic-drugs-reliably-big.html

Published: May 21, 2025 15:40

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic medicines at a price that saves patients over 60%, and public and private insurers over 90%, demonstrating the potential of the…

Small molecules in plant-based foods may reduce efficacy of anti-cancer drugs

https://medicalxpress.com/news/2025-05-small-molecules-based-foods-efficacy.html

Published: May 21, 2025 15:25

A Ludwig Cancer Research study has uncovered a surprising link between diet, intestinal microbes and the efficacy of cancer therapy.

Pulmonary fibrosis: Nerandomilast inhibits phosphodiesterase 4B, may treat multiple forms of disease

https://medicalxpress.com/news/2025-05-pulmonary-fibrosis-nerandomilast-inhibits-phosphodiesterase.html

Published: May 21, 2025 15:12

A new drug for pulmonary fibrosis has reduced disease progression by more than 50% over a 52-week treatment in two clinical trials. Pulmonary fibrosis is a very serious disease, with a life prognosis of 3 to 5 years after diagnosis. But the new drug,…

Promising results of niraparib appear in patients with advanced melanoma

https://medicalxpress.com/news/2025-05-results-niraparib-patients-advanced-melanoma.html

Published: May 21, 2025 15:07

Researchers at Sutter's California Pacific Medical Center (CPMC) in San Francisco, Calif. have discovered early signs of clinical benefit while testing niraparib, a PARP inhibitor, in patients with advanced melanoma whose tumors had specific genetic…

Proposed algorithm to assess and de-label false penicillin allergy labels

https://medicalxpress.com/news/2025-05-algorithm-de-false-penicillin-allergy.html

Published: May 21, 2025 10:59

A team of Monash University researchers have successfully piloted an algorithm to identify incorrect penicillin allergy labels and educate patients presenting to community pharmacies.

Combined oral contraceptives triple risk of cryptogenic stroke in young women, new study shows

https://medicalxpress.com/news/2025-05-combined-oral-contraceptives-triple-cryptogenic.html

Published: May 21, 2025 10:58

New research presented today at the European Stroke Organization Conference (ESOC 2025) held in Helsinki, May 21–23, revealed that the use of combined oral contraceptives (OCs) is associated with a threefold increase in the risk of cryptogenic ischemic…

Candidate drug that boosts protective brain protein in mice has potential to treat Alzheimer's disease

https://medicalxpress.com/news/2025-05-candidate-drug-boosts-brain-protein.html

Published: May 21, 2025 09:17

As researchers work to improve treatment of Alzheimer's disease, new research by UCLA Health identified a candidate drug that reduces levels of a toxic form of a protein in the brain caused by the disease and improved memory in mice by boosting production…

How marijuana legalization has affected traditional drug prescriptions

https://medicalxpress.com/news/2025-05-marijuana-legalization-affected-traditional-drug.html

Published: May 21, 2025 04:56

Approval of recreational and medical cannabis laws in most U.S. states has allowed individuals to legally obtain cannabis to treat certain medical ailments that had typically been treated with prescription drugs. New research in Health Economics reveals…

Researchers identify promising treatment for fentanyl-xylazine overdoses

https://medicalxpress.com/news/2025-05-treatment-fentanyl-xylazine-overdoses.html

Published: May 20, 2025 17:26

Researchers at Marshall University have developed a promising treatment strategy to address overdoses involving fentanyl and the veterinary sedative xylazine, a combination increasingly linked to severe health complications and reduced effectiveness of…

Study advances cancer precision therapies by identifying patients who benefit from bexmarilimab treatment

https://medicalxpress.com/news/2025-05-advances-cancer-precision-therapies-patients.html

Published: May 20, 2025 16:41

Researchers at the University of Turku, Finland, have taken a step towards more personalized and effective cancer treatments. A new study has identified the conditions under which the antibody drug bexmarilimab can activate the body's own defense system…

Pharmacists stockpile most common drugs on chance of targeted Trump tariffs

https://medicalxpress.com/news/2025-05-pharmacists-stockpile-common-drugs-chance.html

Published: May 20, 2025 09:43

In the dim basement of a Salt Lake City pharmacy, hundreds of amber-colored plastic pill bottles sit stacked in rows, one man's defensive wall in a tariff war.

Novo Nordisk and US biotech company team up to create obesity pills

https://medicalxpress.com/news/2025-05-novo-nordisk-biotech-company-team.html

Published: May 20, 2025 06:56

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases.

Virtual trial shows combo rescue inhaler nearly halves severe asthma attacks

https://medicalxpress.com/news/2025-05-virtual-trial-combo-inhaler-halves.html

Published: May 19, 2025 17:18

Findings from a first-of-its-kind virtual trial in pulmonary medicine, conducted at Rutgers and many other institutions, suggest adding an inhaled corticosteroid to rescue therapy could sharply reduce the danger of severe attacks for millions of people…

Allopurinol designated as the first orphan drug for Marfan syndrome treatment

https://medicalxpress.com/news/2025-05-allopurinol-orphan-drug-marfan-syndrome.html

Published: May 19, 2025 16:54

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which has no cure to date. This disease causes an aortic aneurysm (an abnormal dilation of the…

Study suggests dosing of heart failure medication can be safely simplified

https://medicalxpress.com/news/2025-05-dosing-heart-failure-medication-safely.html

Published: May 19, 2025 15:46

An estimated 32 million people globally have heart failure with reduced ejection fraction, a condition where the lower left chamber of the heart does a poor job of pumping blood to the rest of the body.

Drug typically used for opioid addiction could be long COVID treatment

https://medicalxpress.com/news/2025-05-drug-typically-opioid-addiction-covid.html

Published: May 19, 2025 13:11

Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a Griffith University study, published in Frontiers in Molecular Biosciences, found it restored cellular function in human cells.

Amiloride found to be as effective as spironolactone in managing resistant hypertension

https://medicalxpress.com/news/2025-05-amiloride-effective-spironolactone-resistant-hypertension.html

Published: May 19, 2025 11:30

Yonsei University College of Medicine-led research has shown amiloride is as effective as spironolactone in reducing systolic blood pressure (SBP) over 12 weeks in patients with resistant hypertension.

Methotrexate as effective as prednisone in pulmonary sarcoidosis, research finds

https://medicalxpress.com/news/2025-05-methotrexate-effective-prednisone-pulmonary-sarcoidosis.html

Published: May 18, 2025 12:20

Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted side effects. Now new research, published at the ATS 2025 International Conference and in the American Journal of Respiratory and…

Branched-chain amino acids supplements may harm male bodybuilders' fertility

https://medicalxpress.com/news/2025-05-chain-amino-acids-supplements-male.html

Published: May 16, 2025 12:27

A new study published in Zygote reveals that common over-the-counter supplements popular with male bodybuilders and athletes may impact their fertility. This study comes amid a global decline in male fertility.

New discovery about how acetaminophen works could improve understanding about pain relievers

https://medicalxpress.com/news/2025-05-discovery-acetaminophen-pain-relievers.html

Published: May 16, 2025 11:41

A new study from Indiana University scientists may aid the pharmaceutical industry in better understanding a popular over-the-counter pain reliever: Tylenol.

How common drugs can help viruses spread

https://medicalxpress.com/news/2025-05-common-drugs-viruses.html

Published: May 15, 2025 13:40

Drugs are supposed to help us get rid of disease, or at least alleviate the symptoms of them. It is therefore particularly unfortunate that—on the contrary— drugs can contribute to making us sicker. Many medications can have side effects, but some are…

Researchers highlight the limitations and risks of semaglutide

https://medicalxpress.com/news/2025-05-highlight-limitations-semaglutide.html

Published: May 15, 2025 11:05

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide highlighted in a letter published in the JAMA Cardiology.

Family doctors' research on medication dosage timing answers critical questions that 'otherwise don't get asked'

https://medicalxpress.com/news/2025-05-family-doctors-medication-dosage-critical.html

Published: May 15, 2025 08:31

A University of Alberta-led study has put to rest a long-standing controversy about the best time of day to take blood pressure medications—and in the process has created a powerful research network of family doctors to answer important primary care…

Ajovy clinical trial shows little improvement over placebo in migraine and depression

https://medicalxpress.com/news/2025-05-ajovy-clinical-trial-placebo-migraine.html

Published: May 15, 2025 06:55

Albert Einstein College of Medicine and Teva Pharmaceuticals, in collaboration with multiple international institutions, report findings on the efficacy of fremanezumab (sold as Ajovy by Teva) in reducing migraine frequency and depressive symptoms among…

Daratumumab may help cancer patients with low physical function to live longer, study finds

https://medicalxpress.com/news/2025-05-daratumumab-cancer-patients-physical-function.html

Published: May 14, 2025 17:07

How cancer patients relying on daratumumab feel physically before starting the therapy can predict how long they will live and how well they will respond to the anti-multiple myeloma (MM) drug, according to a new study published in the European Journal of…

Low-cost formulation reduces dose and increases efficacy of drug against parasitic worms

https://medicalxpress.com/news/2025-05-dose-efficacy-drug-parasitic-worms.html

Published: May 14, 2025 16:09

A group of researchers has developed a new formulation for the only drug available on the market to treat helminths, as worms such as schistosomes and tapeworms are known. According to the World Health Organization (WHO), 400 million people worldwide…

Research raises concerns about the safety of long-term ADHD medication treatment in children

https://medicalxpress.com/news/2025-05-safety-term-adhd-medication-treatment.html

Published: May 14, 2025 15:50

A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance Institution Kela reveals that the average duration of ADHD medication for children and adolescents is more than three years. However,…

GSK buys liver disease drug for up to $2 bn

https://medicalxpress.com/news/2025-05-gsk-buys-liver-disease-drug.html

Published: May 14, 2025 11:25

British pharmaceutical giant GlaxoSmithKline announced Wednesday the acquisition of a drug under development to treat a common form of liver disease, in a deal worth up to $2 billion.

Experimental compounds show promise for Alzheimer's and pain treatment in animal models

https://medicalxpress.com/news/2025-05-experimental-compounds-alzheimer-pain-treatment.html

Published: May 14, 2025 11:10

A study published in the Journal of Medicinal Chemistry presents a new family of candidate compounds for the treatment of Alzheimer's disease and pain, which have shown promising effects in animal models.

Using an inhaler alone may not be enough to manage asthma

https://medicalxpress.com/news/2025-05-inhaler-asthma.html

Published: May 14, 2025 08:43

Inhalers have been key to asthma management since the 1950s. The most common, salbutamol, comes in a familiar blue-colored inhaler (or "puffer").

Traditional Chinese medicinal fungi might show potential for central nervous system diseases

https://medicalxpress.com/news/2025-05-traditional-chinese-medicinal-fungi-potential.html

Published: May 14, 2025 07:50

Shandong researchers suggest that edible and medicinal fungi contain bioactive components with therapeutic potential for central nervous system (CNS) diseases. Findings offer evidence for the potential of these fungi to serve as novel pharmaceuticals or…

Study finds long-term eczema treatment benefits patients with delayed response

https://medicalxpress.com/news/2025-05-term-eczema-treatment-benefits-patients.html

Published: May 13, 2025 12:46

New research from the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai reveals that patients with moderate-to-severe atopic dermatitis (eczema) who did not initially respond to biologic treatment may…

Targeted approach to treating aggressive breast cancers shows significant improvement in survival

https://medicalxpress.com/news/2025-05-approach-aggressive-breast-cancers-significant.html

Published: May 13, 2025 11:00

A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers.

Lower doses of the GLP-1 agonist medication as effective as higher ones, Danish study finds

https://medicalxpress.com/news/2025-05-doses-glp-agonist-medication-effective.html

Published: May 13, 2025 09:50

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity clinic achieved similar weight loss to that reported in clinical trials—but with less than half the medication. The study is to be…

Interruptions disrupt pharmacy flow, risking safety

https://medicalxpress.com/news/2025-05-disrupt-pharmacy-safety.html

Published: May 13, 2025 08:41

A new study has found that phone calls, face-to-face consumer inquiries and out-of-scope questions from staff are the main sources of distraction during the dispensing process in pharmacy settings.

No link between ADHD meds and psychosis, study says

https://medicalxpress.com/news/2025-05-link-adhd-meds-psychosis.html

Published: May 13, 2025 07:30

ADHD stimulant meds don't increase children's risk of psychosis, a new study says.

Migraine drug can also help with symptoms that occur before the actual headache begins

https://medicalxpress.com/news/2025-05-migraine-drug-symptoms-actual-headache.html

Published: May 12, 2025 15:40

A drug to treat migraine, ubrogepant, is also found to reduce common non-headache symptoms that occur in the hours preceding a migraine headache, according to the results of a large phase three clinical trial published in Nature Medicine. The findings…

Social, cultural and economic status can affect risk of receiving risky medication

https://medicalxpress.com/news/2025-05-social-cultural-economic-status-affect.html

Published: May 12, 2025 15:40

People with low wealth and income have up to 85% higher risk of receiving risky medication compared to the most affluent Danes. This is shown by a comprehensive national study led by researchers from Aarhus University, published in the journal PLOS…

Mepolizumab yields lower rate of moderate/severe exacerbations in COPD

https://medicalxpress.com/news/2025-05-mepolizumab-yields-moderatesevere-exacerbations-copd.html

Published: May 12, 2025 14:30

For patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbations and a blood eosinophil count of at least 300 cells/µL, mepolizumab leads to a lower annualized rate of moderate or severe exacerbations, according to a study…

Zepbound outperforms Wegovy in head-to-head weight loss study

https://medicalxpress.com/news/2025-05-zepbound-outperforms-wegovy-weight-loss.html

Published: May 12, 2025 12:50

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk's Wegovy.

Endometriosis: Daily pill to manage symptoms will soon be available on the NHS—here's how linzagolix works

https://medicalxpress.com/news/2025-05-endometriosis-daily-pill-symptoms-nhs.html

Published: May 12, 2025 11:24

A daily pill to treat endometriosis has just been recommended by the National Institute for Health and Care Excellence (Nice). Once available on the NHS, linzagolix will provide a new treatment option for those who have been unable to manage the condition…

Molecular approach prolongs ketamine's antidepressant effects in mice by weeks

https://medicalxpress.com/news/2025-05-molecular-approach-prolongs-ketamine-antidepressant.html

Published: May 12, 2025 11:20

Researchers at Vanderbilt University identified a molecular approach to extend the antidepressant effects of ketamine in mice by applying BCI, a compound that inhibits DUSP6 to sustain ERK pathway activation. Findings suggest that BCI modulates the…

Do wellness patches work? How to tell the good from the bad

https://medicalxpress.com/news/2025-05-wellness-patches-good-bad.html

Published: May 12, 2025 11:16

From sleep aids and stress relief to vitamins and energy boosts, wellness patches are surging in popularity. These stick-on supplements promise to deliver nutrients and plant-based compounds directly through your skin and into your bloodstream—no pills, no…

Drug to slow Alzheimer's well tolerated outside of clinical trial setting, study finds

https://medicalxpress.com/news/2025-05-drug-alzheimer-tolerated-clinical-trial.html

Published: May 12, 2025 11:00

The Food and Drug Administration's approval in 2023 of lecanemab—a novel Alzheimer's therapy shown in clinical trials to modestly slow disease progression—was met with enthusiasm by many in the field as it represented the first medication of its kind able…

Trump says will sign order aimed at cutting US drug prices

https://medicalxpress.com/news/2025-05-trump-aimed-drug-prices.html

Published: May 12, 2025 05:15

President Donald Trump unveiled plans Sunday for a new policy on pharmaceuticals he claimed would reduce US prescription drug prices by between 30% and 80%.

Opioid prescribing standards changed practices in British Columbia, but with caveats

https://medicalxpress.com/news/2025-05-opioid-standards-british-columbia-caveats.html

Published: May 12, 2025 00:10

In an effort to curb misuse of opioids and prevent overdose deaths, the College of Physicians and Surgeons of British Columbia released a legally enforceable practice standard, "Safe Prescribing of Drugs with Potential for Misuse/Diversion," in 2016. This…

Weight-loss drugs cut alcohol intake by almost two-thirds, research in Ireland suggests

https://medicalxpress.com/news/2025-05-weight-loss-drugs-alcohol-intake.html

Published: May 9, 2025 18:10

Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four months, new research presented at the European Congress on Obesity (ECO 2025) has found.

Cholesterol pill helps those at high risk of heart attack and stroke: Study

https://medicalxpress.com/news/2025-05-cholesterol-pill-high-heart.html

Published: May 9, 2025 11:19

A Monash-led international study has found a cholesterol-lowering drug may offer a more effective and convenient way to protect people at high risk of heart attack and stroke.

Americans' use of illicit opioids is higher than previously reported, survey finds

https://medicalxpress.com/news/2025-05-americans-illicit-opioids-higher-previously.html

Published: May 9, 2025 11:00

More Americans use illicit opioids such as fentanyl than previously estimated, highlighting the need for better methods to understand the depths of the opioid crisis, according to a new study.

Foam treatment rapidly relieves itch and clears stubborn scalp psoriasis lesions

https://medicalxpress.com/news/2025-05-foam-treatment-rapidly-relieves-stubborn.html

Published: May 9, 2025 09:12

Research led by the SKiN Center for Dermatology observed substantial clearance of scalp and body psoriasis and rapid itch reduction in patients treated with roflumilast foam, 0.3%. Findings indicated significantly higher rates of clinical improvement in…

Fighting infections while expecting: Research examines safe antibiotic use during pregnancy

https://medicalxpress.com/news/2025-05-infections-safe-antibiotic-pregnancy.html

Published: May 9, 2025 07:08

Pregnant women often think--or are told--that they cannot take medications during pregnancy to avoid harming the mom or baby. But one University of Mississippi professor is hoping new research will help medical professionals reexamine those…

When statins aren't enough, this drug may help lower 'bad' cholesterol

https://medicalxpress.com/news/2025-05-statins-drug-bad-cholesterol.html

Published: May 8, 2025 16:01

A new drug combo lowers "bad" LDL cholesterol for people whose levels remain high even after taking statins. The new pill pairs a new drug called obicetrapib with an existing one, ezetimibe. In a Phase 3 clinical trial, this combo reduced LDL levels by…

Wireless device enables precise activation of light-sensitive pain drugs in animal study

https://medicalxpress.com/news/2025-05-wireless-device-enables-precise-sensitive.html

Published: May 8, 2025 14:58

Photoactivable drugs are activated when irradiated by a beam of light—via an optical fiber—thus generating a controlled and local therapeutic effect on target tissues. Now, a scientific team has pioneered a new breakthrough in the field of…

HIV drugs offer 'substantial' Alzheimer's protection, new research suggests

https://medicalxpress.com/news/2025-05-hiv-drugs-substantial-alzheimer.html

Published: May 8, 2025 13:11

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's disease after discovering that patients taking the drugs are substantially less likely to develop the condition. The researchers…

Despite historic indictment, doctors will keep mailing abortion pills across state lines

https://medicalxpress.com/news/2025-05-historic-indictment-doctors-mailing-abortion.html

Published: May 8, 2025 10:20

When the news broke on Jan. 31 that a New York physician had been indicted for shipping abortion medications to a woman in Louisiana, it stoked fear across the network of doctors and medical clinics who engage in similar work.

Moxidectin could provide a faster route to eliminating parasitic infection endemic to Africa

https://medicalxpress.com/news/2025-05-moxidectin-faster-route-parasitic-infection.html

Published: May 7, 2025 15:14

Tens of millions of people in Africa are infected by parasitic worms that cause lymphatic filariasis (also called elephantiasis), a disease that leads to severe swelling and deformities of the limbs and genitals. Despite widespread treatment programs that…

Quality improvement program aids antibiotic duration for common infections in children

https://medicalxpress.com/news/2025-05-quality-aids-antibiotic-duration-common.html

Published: May 7, 2025 13:10

A quality improvement program can improve recommended antibiotic duration in children for both acute otitis media (AOM) and community-acquired pneumonia (CAP) across multiple care delivery settings, according to a study presented at the annual meeting of…

Metformin may improve strength and mobility for geriatric men with functional disabilities

https://medicalxpress.com/news/2025-05-metformin-strength-mobility-geriatric-men.html

Published: May 7, 2025 12:29

Metformin, touted as the world's most used anti-diabetic drug, has the potential to improve old age disabilities, such as muscle weakness and poor physical performance, according to University of Sharjah researchers.

Race and ethnicity often not reported in trials of medications for mental health conditions

https://medicalxpress.com/news/2025-05-ethnicity-trials-medications-mental-health.html

Published: May 7, 2025 11:00

A new study led by the University of Southampton has found that the race and ethnicity of participants in clinical trials of medications for mental health and neurodevelopmental conditions often go unrecorded.

NC bill to allow non-prescription use of ivermectin reignites COVID controversy

https://medicalxpress.com/news/2025-05-nc-bill-prescription-ivermectin-reignites.html

Published: May 7, 2025 09:00

A drug that gained international attention for its controversial off-label use during the COVID-19 pandemic could soon be available in North Carolina without a prescription.

How a cholesterol drug may prevent heart attacks

https://medicalxpress.com/news/2025-05-cholesterol-drug-heart.html

Published: May 6, 2025 15:47

A new study conducted at Cedars-Sinai reveals how the cholesterol-reducing drug evolocumab prevents heart attacks in people with coronary artery disease—a leading cause of death in the United States.

Q&A: SSRI use in pregnancy and risk of depression in teens

https://medicalxpress.com/news/2025-05-qa-ssri-pregnancy-depression-teens.html

Published: May 6, 2025 15:33

Nearly two decades ago, Columbia researchers who were using mouse models to better understand the role of serotonin in depression got results that left them baffled.

Alzheimer's: Certain combinations of prescription drugs may slow progression of disease, according to mice study

https://medicalxpress.com/news/2025-05-alzheimer-combinations-prescription-drugs-disease.html

Published: May 6, 2025 13:10

Millions of older adults take five or more prescription drugs every day to manage chronic illnesses. While polypharmacy is often necessary, this practice has also been linked to many negative health outcomes in older adults—including memory problems,…

Pooled buying can reduce costs of life-saving drugs, but planning is key

https://medicalxpress.com/news/2025-05-pooled-buying-life-drugs-key.html

Published: May 6, 2025 12:23

Pooling orders for life-saving medicines can help drive down their cost and ensure a steady supply for low- and middle-income countries, though there are trade-offs, according to a new study led by a University of Massachusetts health economist and…

Lifesaving opioid addiction meds are rarely started after emergency visits for overdose

https://medicalxpress.com/news/2025-05-lifesaving-opioid-addiction-meds-rarely.html

Published: May 6, 2025 11:49

Medications proven to effectively treat opioid addiction are rarely given after emergency department visits for overdose, and who gets them varies, sometimes greatly, depending on race, ethnicity or geography, University of Michigan researchers say.

Diabetes drug shows potential to slow prostate cancer cell growth

https://medicalxpress.com/news/2025-05-diabetes-drug-potential-prostate-cancer.html

Published: May 6, 2025 10:54

An international team of scientists led by the Medical University of Vienna has identified similarities in the mechanisms of diabetes and cancer: as the researchers show, the protein PPARγ, which is central to the regulation of metabolic processes, can…

Nearly quarter of people on long-acting opioids develop addiction, study reveals

https://medicalxpress.com/news/2025-05-quarter-people-opioids-addiction-reveals.html

Published: May 6, 2025 06:50

More than one in five people prescribed extended-release painkillers such as OxyContin developed an addiction within a year, according to a newly released study mandated by the U.S. Food and Drug Administration.

Single-dose gel clears ear infections in animal study within 24 hours

https://medicalxpress.com/news/2025-05-dose-gel-ear-infections-animal.html

Published: May 5, 2025 16:56

Ear infections are a common and painful occurrence in infants and toddlers. Oral antibiotics are often prescribed for a week to treat the condition, but these drugs can trigger side effects that disrupt treatment, which can lead to infection recurrence and…

Drug resistance worsens UTI crisis in Malawi

https://medicalxpress.com/news/2025-05-drug-resistance-worsens-uti-crisis.html

Published: May 5, 2025 14:18

A growing resistance to antibiotics is complicating the treatment of urinary tract infections (UTIs) in Malawi, with new research revealing that nearly half of women presenting with symptoms at a major referral hospital had infections resistant to multiple…

Preterm infant with drug-resistant seizures responds to antisense oligonucleotide treatment

https://medicalxpress.com/news/2025-05-preterm-infant-drug-resistant-seizures.html

Published: May 5, 2025 10:00

Ludwig-Maximilians-Universität München-led researchers have induced a greater than 60% reduction in seizure frequency in a preterm infant with early-onset SCN2A developmental and epileptic encephalopathy (DEE). Seizures initially occurred at a rate of 20…

Promising Parkinson's drug decoded

https://medicalxpress.com/news/2025-05-parkinson-drug-decoded.html

Published: May 5, 2025 09:55

How well our brain functions depends heavily on the performance of our nerve cells. That is why they are regularly checked for their proper function—defective cell components are marked, disposed of and recycled. This includes the mitochondria, the…